---
layout: page
title: "Evidence-based recommendations for intepregnancy intervals and family planning"
---

Interpregnancy interval (IPI) is the time between birth and start of the next pregnancy with short IPI linked to adverse maternal and child health outcomes.  The current World Health Organisation (WHO) recommendations for IPI are heavily driven by studies on low-middle income populations, where women’s recovery time must be considered against a background of nutritional depletion and extraordinary burden of disease. The current obstetric recommendations to wait at least 18-24 months after live birth before trying to conceive again are not necessarily relevant in high-income countries, where the changing obstetric profile (increasing maternal age, increasing caesarean section rates and increasing chronic morbidities) is most relevant. Importantly, IPI recommendations must be balanced against an increasing prevalence of women starting a family later in life. For the majority of women, the harms of longer IPIs at advanced maternal age might outweigh the benefits of avoiding adverse pregnancy outcomes associated with shorter IPIs. 

We discovered that there is insufficient evidence to suggest short IPI is harmful after experiencing a stillbirth.Based on findings from our international research we also discovered that the harms of short IPI are present, but are much smaller than once thought. The following figure shows odds ratios for effects of IPI on preterm birth for four high-income countries. Points (odds ratios) to the right of the vertical line indicate harm. Horizontal lines indicate certainty (95% confidence intervals). The diamonds represent the estimate for all countries together (pooled meta-analysis estimates). 

<img src="https://journals.plos.org/plosone/article/figure/image?size=large&id=info:doi/10.1371/journal.pone.0255000.g001" width="600" alt="IPI and PTB">


[Source:PLoS One 16 (7)](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255000)

Project lead: [Prof Gavin Pereira](https://gavinfpereira.github.io/pereira lab)

Collaborators: Aarhus University,  Finnish Institute of Health and Welfare, Icahn School of Medicine at Mount Sinai, Karolinska Institute, London School of Hygiene and Tropical Medicine, Norwegian Institute of Public Health (Folkehelseinstituttet), Queen's University, Stanford University, University of California Los Angeles, University of Haifa, University of San Francisco, University of Sydney, University of Turku
Countries involved: Australia, Canada, Denmark, Israel, Norway, Sweden, United Kingdom, United States


**Publication(s)**
* Gebremedhin, A. T., A. K. Regan, S. Ball, A. P. Betrán, D. Foo, M. Gissler, S. E. Håberg, E. Malacova, M. L. Marinovich, and G. Pereira. 2021. "Interpregnancy interval and hypertensive disorders of pregnancy: A population-based cohort study." Paediatric and Perinatal Epidemiology 35 (4): 404-414
* Marinovich, M. L., A. K. Regan, M. Gissler, M. C. Magnus, S. E. Håberg, J. A. Mayo, G. M. Shaw, J. Bell, N. Nassar, S. Ball, ..., and G. Pereira. 2021. "Associations between interpregnancy interval and preterm birth by previous preterm birth status in four high-income countries: a cohort study." BJOG: An International Journal of Obstetrics and Gynaecology 128 (7): 1134-1143
* [Dhamrait, G. K., C. L. Taylor, and G. Pereira. "Interpregnancy intervals and child development at age 5: A population data linkage study." BMJ Open 11 (3)](https://bmjopen.bmj.com/content/11/3/e045319)
* Gebremedhin, A. T., G. A. Tessema, A. K. Regan, and G. Pereira. 2021. "Association between interpregnancy interval and hypertensive disorders of pregnancy: Effect modification by maternal age." Paediatric and Perinatal Epidemiology 35 (4): 415-424
* [Tessema, G. A., M. L. Marinovich, S. E. Håberg, M. Gissler, J. A. Mayo, N. Nassar, S. Ball, A. P. Betrán, A. T. Gebremedhin, N. de Klerk,... , and G. Pereira. 2021. "Interpregnancy intervals and adverse birth outcomes in high-income countries: An international cohort study." PLoS One 16 (7)](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255000)
* Regan, A. K., A. Arnaout, L. Marinovich, C. Marston, I. Patino, R. Kaur, A. Gebremedhin, and G. Pereira. 2020. "Interpregnancy interval and risk of perinatal death: a systematic review and meta-analysis." BJOG: An International Journal of Obstetrics and Gynaecology 127 (12): 1470-1479
* Regan, A. K., M. Gissler, M. C. Magnus, S. E. Håberg, S. Ball, E. Malacova, N. Nassar, H. Leonard, and G. Pereira. 2019. "Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study." The Lancet 393 (10180): 1527-1535
* Gebremedhin, A. T., A. K. Regan, S. Ball, A. P. Betrán, D. Foo, M. Gissler, S. E. Håberg, E. Malacova, M. L. Marinovich, and G. Pereira. 2019. "Effect of interpregnancy interval on gestational diabetes: a retrospective matched cohort study." Annals of Epidemiology 39: 33-38.e3
* [Marinovich, M. L., A. K. Regan, M. Gissler, M. C. Magnus, S. E. Håberg, A. M. Padula, J. A. Mayo, G. M. Shaw, S. Ball, E. Malacova, ...., and G. Pereira 2019. "Developing evidence-based recommendations for optimal interpregnancy intervals in high-income countries: Protocol for an international cohort study." BMJ Open 9 (1)](https://bmjopen.bmj.com/content/9/1/e027941)
* [Ball, S. J., G. Pereira, P. Jacoby, N. de Klerk, and F. J. Stanley. 2014. "Re-evaluation of link between interpregnancy interval and adverse birth outcomes: retrospective cohort study matching two intervals per mother." BMJ: British Medical Journal 349 (jul23 1): g4333-g4333](https://www.bmj.com/content/349/bmj.g4333.long)
